Formulations for cgrp receptor antagonists

Formulations for cgrp receptor antagonists

  • CN 105,531,275 A
  • Filed: 09/11/2014
  • Published: 04/27/2016
  • Est. Priority Date: 09/16/2013
  • Status: Active Grant
First Claim
Patent Images

1. a composition of liquid medicine, it comprises (S)-N-((3S, 5S, 6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl) piperidines-3-base)-2 '"'"'-oxo-1 '"'"', 2 '"'"', 5,7-tetrahydrochysene spiral shell [cyclopentano [b] pyridine-6,3 '"'"'-pyrrolo-[2,3-b] pyridine]-3-methane amide or its pharmaceutical salts and pharmaceutical carrier, the volume of wherein said carrier is less than 10mL.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×